Cancer Drug: Is It Worth The Expense

Cancer Drug: Is It Worth The Expense

Photo: Newsradio WTAX

For the first time in a decade, an experimental drug has extended the life of patients with advanced lung cancer who relapsed after standard chemotherapy. But the benefit in the study was so small — six extra weeks, on average — that it is raising fresh questions about the value of some costly new cancer medicines.

Eli Lilly and Company’s drug Cyramza was tested in more than 1,200 patients. It is sold now for stomach cancer and costs $6,000 per infusion.

The study was discussed Saturday at a cancer conference where doctors also reported progress with new drugs against relapsed ovarian cancer and chronic lymphocytic leukemia, the most common type of leukemia in adults.

Recent Headlines

in Entertainment

WATCH: 7 fun facts to make you think this Thanksgiving


Thanksgiving is a time of coming together with family and friends. In between bites of stuffing and pumpkin pie, snack on these unusual Turkey Day facts.

in Black Friday, Entertainment

Change your Amazon password now


With Black Friday and Cyber Monday quickly approaching, this might be the worst time of year for Amazon to have security concerns.

in Black Friday, Entertainment

PHOTOS: Macy’s Parade through the years


For 88 years the iconic Macy's Parade has been a Thanksgiving tradition.